Prognostic value of AI-enabled quantitative coronary CT angiography for major adverse cardiovascular events: A systematic review and meta-analysis
International Journal of Cardiology Cardiovascular Risk and Prevention · 2026-09 · 30 · 200660
DOI: 10.1016/j.ijcrp.2026.200660 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Cardiology Cardiovascular Risk and Prevention, 2026-09. Verfasst von Mushrin Malik und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beth Israel Deaconess Medical Center, MA, USA. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Artificial intelligence-enabled quantitative coronary computed tomography angiography (AI-QCCTA) offers automated assessment of coronary plaque burden and morphology. Although AI-QCCTA has improved diagnostic consistency and downstream testing efficiency, its prognostic value for major adverse cardiovascular events (MACE) has not been comprehensively quantified.
Methods
We systematically searched PubMed, Embase, and Cochrane through October 2025 for studies evaluating AI-based plaque analysis in patients without prior MACE undergoing CCTA. Outcomes of interest were pooled using random-effects GLMM models, and prognostic associations were synthesized using inverse-variance random-effects meta-analysis of hazard ratios (HRs). The primary endpoint was MACE; secondary outcomes included myocardial infarction (MI), revascularization, angina, stroke, and mortality. Subgroup analysis was done to identify the association of different plaque characteristics in predicting MACE/MI/Death.
Results
Ten studies (n = 20,195) were included. Across six cohorts (n = 18,804), pooled rates were: all-cause mortality 1.20% (95% CI 0.38-3.77%), cardiovascular mortality 0.32% (0.21-0.48%), MACE 5.07% (1.25-18.46%), MI 1.30% (0.41-3.99%), and revascularization 13.09% (6.57-24.40%). AI-enabled plaque burden predicted MACE (HR 1.95, 95% CI 1.29-2.94; I2 = 99%), consistent in sensitivity analysis as per same AI platform use (HR 1.88, 95% CI 1.15-3.07). Low-attenuation plaque showed the strongest association (HR 2.95, 95% CI 1.95-4.45).
Conclusions
AI-QCCTA provides prognostic value beyond stenosis severity, with vulnerable plaque characteristics-particularly low-attenuation and non-calcified plaque most strongly predicting adverse cardiovascular outcomes. These findings support the integration of AI-enabled plaque analysis into contemporary risk stratification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beth Israel Deaconess Medical Center, MA, USA.
- Universidade Federal da Paraíba, Paraíba, Brazil.
- Federal University of Rio Grande Do Norte, Natal, RN, Brazil.
- University of Pernambuco, Recife, PE, Brazil.
- Federal University of Ceara, Fortaleza, Ceara, Brazil.
- University Center for the Development of Alto Vale - UNIDAVI, Medical Sciences Research Center, Rio Do Sul, Brazil.
Zitieren
APA
Malik, M., Batista, P., Lucena, L. A., Montenegro, M. V., Santos Silva, R. R. A., Fischer-Bacca, C. O., Giorgi, J., & Strom, J. (2026). Prognostic value of AI-enabled quantitative coronary CT angiography for major adverse cardiovascular events: A systematic review and meta-analysis. International Journal of Cardiology Cardiovascular Risk and Prevention, 30, 200660. https://doi.org/10.1016/j.ijcrp.2026.200660
Vancouver
Malik M, Batista P, Lucena LA, Montenegro MV, Santos Silva RRA, Fischer-Bacca CO, et al. Prognostic value of AI-enabled quantitative coronary CT angiography for major adverse cardiovascular events: A systematic review and meta-analysis. International Journal of Cardiology Cardiovascular Risk and Prevention. 2026;30:200660. doi:10.1016/j.ijcrp.2026.200660
BibTeX
@article{Malik2026,
author = {Malik, Mushrin and Batista, Pedro and Lucena, Larissa Araújo de and Montenegro, Marcela Vasconcelos and Santos Silva, Railla Raquel Albino and Fischer-Bacca, Caroline O and Giorgi, Juliana and Strom, Jordan},
title = {Prognostic value of AI-enabled quantitative coronary CT angiography for major adverse cardiovascular events: A systematic review and meta-analysis},
journal = {International Journal of Cardiology Cardiovascular Risk and Prevention},
year = {2026},
volume = {30},
pages = {200660},
doi = {10.1016/j.ijcrp.2026.200660}
}
EUVIMED